The landscape of dementia diagnosis has evolved radically with the appearance of subtle biomarkers, which include amyloid PET scans, tau imaging, and blood-primarily based assessments that can detect Alzheimer's pathology a long time right before signs arise. Though these technological developments characterize outstanding progress in knowledge neu